Abbasi et al. evaluate the value of source data verification, a costly but traditional element of clinical trials. They find it is largely redundant when used with a systematic strategy to promote efficient and accurate data capture, monitoring, and safety in a phase II platform trial.
Trial Registration: https://clinicaltrials.gov/study/NCT04488081
- Ali B. Abbasi
- Kathleen D. Liu
- Alejandro Botello Barragan
